RELMADA THERAPEUTICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
RELMADA THERAPEUTICS, INC. (RLMD) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $2.82 per share for the 1-month period ending 2023-12-15, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2025-03-27
- 2023-12-15: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 1 month $2.82.
- 2023-09-18: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 2 month $2.96.
- 2023-06-20: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 2 month $3.32.
- 2023-02-21: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 2 month $4.30.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 0 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 1 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 2 month |
|---|---|---|---|
| 2023-12-15 | $2.82 10-K · filed 2025-03-27 | ||
| 2023-09-18 | $2.96 10-K · filed 2025-03-27 | ||
| 2023-06-20 | $3.32 10-K · filed 2025-03-27 | ||
| 2023-02-21 | $4.30 10-K · filed 2025-03-27 | ||
| 2022-12-21 | $3.37 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |